Privia Health Group, Inc. (PRVA) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
PRVA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PRVA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 9.9% | 1.6% | 1.1% |
| 2024 | 10.2% | 1.0% | 0.8% |
| 2023 | 9.7% | 1.2% | 1.4% |
| 2022 | 9.9% | -1.4% | -0.6% |
| 2021 | 6.6% | -22.5% | -19.5% |
Download Data
Export PRVA earnings history in CSV or JSON format
Free sign-in required to download data
Privia Health Group, Inc. (PRVA) Earnings Overview
As of May 8, 2026, Privia Health Group, Inc. (PRVA) reported trailing twelve-month net income of $3.08B, reflecting +63.6% year-over-year growth. The company earned $23.55 per diluted share over the past four quarters, with a net profit margin of 1.1%.
Looking at the long-term picture, PRVA's 5-year EPS compound annual growth rate (CAGR) stands at -9.7%, signaling declining earnings. The company achieved its highest annual net income of $31M in fiscal 2020.
Privia Health Group, Inc. maintains positive profitability with a gross margin of 9.9%, operating margin of 1.6%, and net margin of 1.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AGIO (-$423M net income, -764.0% margin), CNC (-$6.44B net income, -3.4% margin), ALHC ($20M net income, -0.0% margin), PRVA has outperformed on profitability metrics. Compare PRVA vs AGIO →
PRVA Earnings vs Peers
Earnings metrics vs comparable public companies
PRVA Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $23M | +59.3% | $34M | $0.18 | 1.1% | 1.6% |
| 2024 | $14M | -37.7% | $17M | $0.11 | 0.8% | 1.0% |
| 2023 | $23M | +368.8% | $21M | $0.19 | 1.4% | 1.2% |
| 2022 | -$9M | +95.4% | -$19M | $-0.08 | -0.6% | -1.4% |
| 2021 | -$188M | -702.5% | -$217M | $-1.77 | -19.5% | -22.5% |
| 2020 | $31M | +279.0% | $25M | $0.30 | 3.8% | 3.1% |
| 2019 | $8M | +370.8% | $16M | $0.08 | 1.0% | 2.0% |
| 2018 | -$3M | - | $2M | $-0.03 | -0.5% | 0.3% |
See PRVA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRVA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRVA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRVA — Frequently Asked Questions
Quick answers to the most common questions about buying PRVA stock.
Is PRVA growing earnings?
PRVA EPS is $23.55, with earnings growth accelerating to +63.6%. This exceeds the 5-year CAGR of -9.7%. TTM net income reached $3.1B.
What are PRVA's profit margins?
Privia Health Group, Inc. net margin is +1.1%, with operating margin at +1.6%. Below-average margins reflect competitive or cost pressures.
How consistent are PRVA's earnings?
PRVA earnings data spans 2018-2025. The accelerating earnings trend is +63.6% YoY. Historical data enables comparison across business cycles.